1 completed. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Completed 1 |
Follow Relapsing Remitting Multiple Sclerosis: new trials by email Literature Review of Relapsing Remitting Multiple Sclerosis trials Research Report on Relapsing Remitting Multiple Sclerosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Melatonin in Patients With Multiple Sclerosis (MS). 3 mg Melatonin, 5 mg Melatonin - Relapsing Remitting Multiple Sclerosis | Early Phase 1 | Completed | Providence Health & Services | 30 | 2018-05-09 | 2025-03-30 |
Multiple Sclerosis (1) · Multiple Sclerosis, Relapsing-Remitting (1)
Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Demyelinating Autoimmune Diseases, CNS (1) · Demyelinating Diseases (1) · Immune System Diseases (1) · Nervous System Diseases (1)
Melatonin (1)
Providence Health & Services (1)
United States (1)
Kyle Smoot, MD (1)